Interior Banner 2


Flatley Discovery Lab
Suite 208
The Schrafft Center
529 Main St.
Charlestown, MA 02129
Phone: 617-242-0720
Fax: 617-242-0721


From the South:
Take I-93 North toward Boston to Exit 28 Sullivan Square/Charlestown. Turn right on to Cambridge Street. Turn slight right onto Maffa Way. Enter traffic circle (rotary) and take the second exit on to Main Street. The Schrafft Center will be on the left which is 529 Main Street.

From the North:
Take I-93 South to exit 28 toward Sullivan Square /Charlestown. Merge on to Mystic Avenue. Take the I-93 South ramp towards Boston/Sullivan Square Charlestown. Merge on to Broadway. Broadway becomes Maffa Way. Enter traffic circle (rotary) and take the second exit on to Main Street. The Schrafft Center will be on your left which is 529 Main Street.

Public Transportation:
Take the Orange Line to Sullivan Square. Free regular shuttle service to the Schrafft Center.

Free on-site parking.

News & Developments

Oct 10, 2013 Flatley Discovery Lab, LLC Nominates Clinical Candidate for Treatment of Cystic Fibrosis
CHARLESTOWN, Mass.--(PRESS ENTITY)—October 10, 2013—Flatley Discovery Lab, LLC today announced that it has nominated FDL169, an orally available small molecule for the treatment of Cystic Fibrosis, as a clinical candidate and initiated IND-enabling st
Dec 3, 2012 Hub lab seeks wider cystic fibrosis cure
Word last week that the U.S. Food and Drug Administration had approved a drug developed by a Cambridge biotech company to treat a rare form of cystic fibrosis that affects about 1,200 people upped the ante for a lab in neighboring Charlestown...
Dec 3, 2012 Venture firm backs start-ups targeting cystic fibrosis
John Flatley, a real estate developer and philanthropist, has founded an investment group called Flatley Venture Capital to back life sciences start-ups with potential treatments for the genetic disease cystic fibrosis. Flatley, who has a close relative w
Dec 3, 2012 WHOI teaming with Flatley Discovery Lab in search for effective treatments for cystic fibrosis.
The Woods Hole Oceanographic Institution (WHOI) has signed a $1.18 million agreement with the Flatley Discovery Lab in Charlestown, Mass., to investigate and supply marine microbial extracts as possible treatments for cystic fibrosis (CF).